These findings indicate a potential mechanism whereby the upregulation of LDHA contributes to metabolic disorders and proinflammatory responses, consequently affecting the prognostic outcomes of individuals with NAFLD that progresses to HCC. Here, LDHA is linked to metabolic dysfunction-associated steatotic liver disease.